In its decision of 12 September 2022, the Swiss Federal Administrative Court confirmed that interpretive software that uses indicators such as calendar days and body temperature to monitor fertile and infertile phases of a menstrual cycle to achieve natural conception or prevent undesired pregnancy, qualifies as a medical device. This means that such software is subject to a conformity certification procedure with a notified body.
In June 2020, the modernized Swiss company law (grosse Aktienrechtsrevision) was adopted after years of parliamentary discussion. The revision includes updated rules with respect to management compensation for listed companies. Furthermore, the Swiss Confederation adopted new rules on the disclosure of non-financial matters as well as minerals and metals from conflict areas and child labor.